Trond Ulven

Trond Ulven

Professor

Member of:

    ORCID: 0000-0002-8135-1755

    Publication year:
    All
    21 - 30 out of 157Page size: 10
    Sort by: Title
    1. Published

      Antidiabetic enolic glucoside of phenylpyruvic acid.

      Joubert, E., Fey, S. J., Louw, J., Ulven, Trond & Tyagi, R., 12 Apr 2012, Patent No. WO 2012/045363A1

      Research output: Patent

    2. Published

      Autocrine negative feed-back regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT

      Husted, Anna Sofie, Ekberg, J. H., Tripp, E., Nissen, T. A. D., Meijnikman, S., O'Brien, S. L., Ulven, Trond, Acherman, Y., Bruin, S. C., Nieuwdorp, M., Gerhart-Hines, Zach, Calebiro, D., Dragsted, Lars Ove & Schwartz, Thue W., 2020, In: Molecular Metabolism. 42, 10 p., 101103.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival

      Theiler, A., Bärnthaler, T., Platzer, W., Richtig, G., Peinhaupt, M., Rittchen, S., Kargl, J., Ulven, Trond, Marsh, L. M., Marsche, G., Schuligoi, R., Sturm, E. M. & Heinemann, A., 2019, In: The Journal of allergy and clinical immunology. 144, 3, p. 764-776

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      CRTH2 receptor ligands for therapeutic use

      Ulven, Trond, Frimurer, Thomas Michael, Rist, Ø., Kostenis, E., Högberg, T., Receveur, J. & Grimstrup, M., 2005, Patent No. WO 2005/115382 A1

      Research output: Patent

    5. Published

      CRTH2 receptor ligands for therapeutic use - B-series

      Ulven, Trond, Frimurer, Thomas Michael, Rist, Ø., Kostenis, E. & Högberg, T., 2005, Patent No. WO 2005/115374 A1

      Research output: Patent

    6. Published

      Characterising pharmacological ligands to study the long chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4

      Milligan, G., Alvarez-Curto, E., Watterson, K. R., Ulven, Trond & Hudson, B. D., 2015, In: British Journal of Pharmacology. 172, 13, p. 3254-3265 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Chemical synthesis and biological evaluation of cis- and trans-12,13-cyclopropyl and 12,13-cyclobutyl epothilones and related pyridine side chain analogues

      Nicolaou, K. C., Namoto, K., Ritzén, A., Ulven, Trond, Shoji, M., Li, J., D'Amico, G., Liotta, D., French, C. T., Wartmann, M., Altmann, K. H. & Giannakakou, P., 26 Sep 2001, In: American Chemical Society. Journal. 123, 38, p. 9313-9323 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs

      Hudson, B. D., Ulven, Elisabeth Rexen, Tikhonova, I. G., Grundmann, M., Kostenis, E., Adams, D. R., Ulven, Trond & Milligan, G., 2012, In: F A S E B Journal. 26, 12, p. 4951-4965 15 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      Chemogenetics defines a short-chain fatty acid receptor gut-brain axis

      Barki, N., Bolognini, D., Börjesson, U., Jenkins, L., Riddell, J., Hughes, D. I., Ulven, Trond, Hudson, B. D., Ulven, Elisabeth Rexen, Dekker, N., Tobin, A. B. & Milligan, G., 2022, In: eLife. 11, 23 p., e73777.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Complex Pharmacology of Free Fatty Acid Receptors

      Milligan, G., Shimpukade, B., Ulven, Trond & Hudson, B. D., 11 Jan 2017, In: Chemical Reviews. 117, 1, p. 67-110 44 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 3 4 5 6 7 8 ...16 Next

    ID: 187375453